HLA-DQA1, major histocompatibility complex, class II, DQ alpha 1, 3117
N. diseases: 427; N. variants: 101
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.790 | 0.320 | 6 | 32636595 | intron variant | G/A | snv | 0.54 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.827 | 0.280 | 6 | 32638979 | synonymous variant | G/A | snv | 3.0E-05 | 1.8E-03 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.827 | 0.280 | 6 | 32638979 | synonymous variant | G/A | snv | 3.0E-05 | 1.8E-03 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.800 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.827 | 0.280 | 6 | 32638979 | synonymous variant | G/A | snv | 3.0E-05 | 1.8E-03 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | ||||||
|
0.925 | 0.200 | 6 | 32641650 | intron variant | T/C | snv |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
1.000 | 0.120 | 6 | 32642928 | 3 prime UTR variant | G/A;C;T | snv | 1.0E-02 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.790 | 0.320 | 6 | 32636595 | intron variant | G/A | snv | 0.54 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.810 | 1.000 | 4 | 2012 | 2019 | |||||||
|
1.000 | 0.040 | 6 | 32644620 | non coding transcript exon variant | A/G | snv | 0.42 |
|
Digestive System Diseases | 0.800 | 1.000 | 2 | 2012 | 2017 | |||||||
|
0.925 | 0.120 | 6 | 32632222 | intron variant | G/A | snv | 0.55 |
|
Digestive System Diseases; Neoplasms | 0.810 | 1.000 | 2 | 2012 | 2015 | |||||||
|
1.000 | 0.040 | 6 | 32633427 | intron variant | C/G | snv | 5.2E-02 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 32629564 | intron variant | G/A | snv | 4.6E-02 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.925 | 0.120 | 6 | 32637507 | missense variant | G/A | snv | 5.7E-02 | 8.4E-02 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
|
1.000 | 0.040 | 6 | 32628470 | intron variant | G/T | snv | 5.0E-02 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 32632691 | intron variant | G/A | snv | 5.9E-02 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 32633277 | intron variant | C/A;G | snv | 5.0E-02 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 32638205 | intron variant | -/A;G | ins |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
1.000 | 0.120 | 6 | 32634653 | intron variant | C/A | snv | 0.26 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
1.000 | 0.040 | 6 | 32652845 | intergenic variant | A/T | snv | 0.56 |
|
Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.925 | 0.120 | 6 | 32652506 | intergenic variant | C/T | snv | 0.49 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 32637642 | intron variant | -/T | ins |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
1.000 | 0.040 | 6 | 32628532 | intron variant | C/T | snv | 0.76 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 32628698 | intron variant | C/A | snv | 0.27 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.701 | 0.480 | 6 | 32638107 | intron variant | C/T | snv | 3.3E-03 |
|
Neoplasms; Immune System Diseases; Nervous System Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 32639087 | 3 prime UTR variant | T/C | snv | 0.16 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 32639091 | 3 prime UTR variant | T/C | snv | 0.17 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2012 | 2012 |